Physician profile
Stephen Scott
NPI 1780188276
$2,478.24
in general payments reported to CMS, 2019-2025
20 companies · $1,109 in 2025
The $1,109 reported for 2025 was more than what 86% of Adult Medicine providers received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $26.21 · 2023: $291 · 2024: $1,052 · 2025: $1,109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,452.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $979.73 | 2022-2025 | Vraylar, Mavyret |
| Novo Nordisk INC | $346.14 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $280.48 | 2024-2025 | Airsupra, Breztri, Farxiga |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $132.86 | 2024-2025 | Caplyta |
| Lilly USA, LLC | $102.71 | 2024-2025 | Mounjaro, Zepbound |
| Astellas Pharma US INC | $101.94 | 2024-2025 | Veozah |
| Novartis Pharmaceuticals Corporation | $81.79 | 2024 | |
| Pfizer INC. | $69.65 | 2025 | |
| Exact Sciences Corporation | $56.55 | 2024 | Cologuard Collection Kit |
| Amgen INC. | $55.41 | 2025 | Krystexxa, Repatha, Otezla |
| Inspire Medical Systems, INC. | $46.69 | 2025 | Inspire |
| Biotronik Nro, INC. | $45.15 | 2024-2025 | |
| Medtronic, INC. | $38.81 | 2024 | Intellis Adaptivestim, Interstim |
| Saluda Medical Americas, INC. | $26.13 | 2024 | Evoke |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $25.00 | 2025 | Xifaxan |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $23.34 | 2025 | Rexulti |
| Organogenesis INC. | $18.77 | 2024 | |
| Esperion Therapeutics, INC. | $18.55 | 2025 | Nexletol |
| Philips North America LLC | $14.98 | 2024 | (Ck7) Extended Holter |
| Kowa Pharmaceuticals America, INC. | $13.56 | 2024 | Livalo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.